Kapa

Kapa Gold Reports on Recent Site Visit to Past Producing High-Grade Blackhawk Gold Mine

Retrieved on: 
Wednesday, November 30, 2022
Copper, Geology, Tamar Hematite Iron Company, Kapa, Graphite, GOLD, Lead, Temperature, National instrument, Gold, Rehabilitation, News, KAPA, Mining, Consultant, Zinc, Silver, Black Hawk, Uranium

Vancouver, British Columbia--(Newsfile Corp. - November 30, 2022) - KAPA GOLD INC. (TSXV: KAPA) ("Kapa" or the "Company") a gold exploration and development company provides the following report from the recent site visit conducted by management and its consulting geologist during October 2022 at the past producing, high-grade Blackhawk Gold Mine ("Blackhawk").

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - November 30, 2022) - KAPA GOLD INC. (TSXV: KAPA) ("Kapa" or the "Company") a gold exploration and development company provides the following report from the recent site visit conducted by management and its consulting geologist during October 2022 at the past producing, high-grade Blackhawk Gold Mine ("Blackhawk").
  • Blackhawk is situated in an arid environment and consequently mineralized fault zones are accented by intense oxidation, hematitization (Figure 1).
  • David Paxton, Kapa CEO stated, "There is sufficient information of numerous mineralizing events within the Blackhawk licence, including the past producing, high-grade, underground Blackhawk gold mine as the most obvious in addition to skarn mineralization and high-grade limestone.
  • Kapa Gold, led by experienced capital markets and geologic team, is focused on exploring its 100% owned historic Blackhawk Gold Mine and surrounding underexplored properties for economic mineralization.

Roche launches new exome and custom KAPA Target Enrichment portfolio for translational and clinical research applications in sequencing

Retrieved on: 
Tuesday, May 12, 2020
Hawaiiana, Kapa, Culture

KAPA HyperExome is a whole exome research panel with significantly improved performance over the existing on-market SeqCap portfolio and other products on the market.

Key Points: 
  • KAPA HyperExome is a whole exome research panel with significantly improved performance over the existing on-market SeqCap portfolio and other products on the market.
  • In addition to the Target Enrichment portfolio, Roche is also launching the new HyperDesign tool that enables researchers to create custom target enrichment designs that utilize the new KAPA HyperChoice probes.
  • KAPA Target Enrichment portfolio provides the high level of performance and consistency that is needed to empower clinical researchers to process more samples successfully while optimizing sequencing efficiency.
  • The new KAPA HyperExome, KAPA HyperChoice and KAPA HyperExplore probesreplace the SeqCap product portfolio that will be discontinued.